PROM1 and cancer: In vitro studies in sarcoma cell lines have reported that CD133+ cells mark a subpopulation of cancer cells characterized by high expression levels of stemness genes, in vitro self-renewal, and increased clonogenicity and tumorigenicity [19,20,22,23,24,25].